About
Biomatlante, based near Nantes, France, is a leader in synthetic bone graft technologies, offering innovative solutions for bone regeneration. The company specializes in products used in orthopedics, trauma surgery, spine surgery, and dental surgery, with its offerings sold in over 50 countries. Biomatlante is ISO 13485 and MDSAP accredited, adhering to high standards of quality and safety. The core of Biomatlante's product line is the MBCP® Technology platform, which includes various synthetic bone substitutes, resorbable osteosynthesis products, and the MBCP® smart scaffold for bone tissue engineering. Their products are designed to meet the needs of healthcare professionals and institutions, providing effective solutions for challenging clinical cases. Biomatlante is committed to research and innovation, collaborating with universities and research centers to advance the development of next-generation synthetic bone substitutes.
Technologies
Keywords
Company Information
- Employees32
- Founded1995
- Annual Revenue$7500000
- Total Funding$5100000
Location
5 Rue Edouard Belin, Vigneux-de-Bretagne, Pays de la Loire, France, 44360
